The third edition of our X-omics festival “the future of X-omics research is now!” will take place on Monday April 12th 2021.
This event will take place ONLINE!
This event will include:
The X-omics festival 2021 will host poster sessions in a virtual poster hall (combined with a virtual exhibition hall). OMICS researchers can submit a poster abstract for this poster session.
Posters will be presented both as a video and PDF in the poster session. During the breaks of the festival, participants will be able to video talk to you directly (1 on 1 or in small groups) to ask questions about your poster.
From the submitted posters, 5 posters will be selected for a 3 minute pitch during the actual conference. The best poster pitch will be rewarded with an award in the last session of the X-omics festival.
Please submit an abstract in Word format, using max 500 words, including:
After notification of acceptance, please submit a video and PDF of your poster.
Prof Riess, MD, is full professor for Medical Genetics, director of the Institute of Medical Genetics and Applied Genomics, and founder and acting director of the Rare Disease Center Tübingen. He has more than 20 years of experience in clinical genetics and research of genetically caused disorders. Main research focus is on neurodegenerative and syndromal diseases; both from the clinical as well as from the basic research perspective. Special focus on genetically inherited movement disorders such as ataxias, Huntington’s disease, Parkinson’s disease, and dystonia, and on the application of genomic HTP technology in the clinical practise. To faster transfer genomic medicine into university settings he is co-founder of the Center for personalized medicine of the University of Tübingen. His group is also well known for genetically modified rat models of neurodegenerative diseases and for preclinical studies. Current research approaches also include rare cancer syndromes, the development of biomarkers for rare diseases and strategies to solve diagnostically unclear diseases. He currently is and has been coordinator of numerous international, European and national funded consortia such as EUROSCA, MEFOPA, TECHGENE, RATstream, Neuromics, and SOLVE-RD. He is also PI and spokesperson of one of four DFG funded NGS Competence Centers in Germany. OR serves in numerous advisory boards such as the German initiative for Rare Diseases (NAMSE), the EFSN task force on spinocerebellar ataxias, the executive member of the Ataxia study group (ASG), as a board member of the International Rare Disease Research Consortium IRDiRC (Diagnostics Scientific Committee), and most recently to the Ministry of Health on the implementation of genome diagnostics into the health care system. For several years he was also a board member of the study section Neuroscience (Fachgutachter) of the German Research Foundation (DFG) and an associated Member of the Commission on genetic diagnostics (Gendiagnostik-Kommission) of the Ministry of Health (BfG). He is an active member of three European Reference Networks (ERNs). From 2016 to 2017 he served as President of the European Society of Human Genetics (ESHG) and he is currently Vice president of the German Human Genetics Society. Published >400 papers.